This compound is a brominated tetrazole derivative used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients. Its structure features a trityl-protected tetrazole ring and a bromomethyl-substituted biphenyl group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-[4-[(2-butyl-4-chloro-5-formylimidazol-1-yl)methyl]phenyl]benzonitrile
pharmaceutical intermediate
Tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
pharmaceutical intermediate
Benzyloxycarbonyl valacyclovir
pharmaceutical intermediate
(R)-3-Aminohexahydroazepine
pharmaceutical intermediate
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole
pharmaceutical intermediate
The international HS code for 5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1h-tetraazole (CAS 124750-51-2) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
5-[2-[4-(bromomethyl)phenyl]phenyl]-1-trityltetrazole
ZTFVTXDWDFIQEU-UHFFFAOYSA-N
C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)N4C(=NN=N4)C5=CC=CC=C5C6=CC=C(C=C6)CBr
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.